Abstract
Upcoming clinical trials assessing transplantation of stem cell-derived dopaminergic neurons into the striatum in patients with Parkinson's disease could generate groundbreaking results on neuronal replacement in the human brain. However, as highlighted here, the road toward a clinically competitive treatment for this multisystem disorder will probably be long and winding.
Original language | English |
---|---|
Pages (from-to) | 519-522 |
Number of pages | 4 |
Journal | Cell Stem Cell |
Volume | 27 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2020 |
Subject classification (UKÄ)
- Neurosciences